Ashton, F. E. et al., Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide, Microbial Pathog. 6:455-458 (1989). |
Barlow, A. K. et al., Molecular Cloning and Expression of Neisseria meningitidis Class 1 Outer Membrane Protein in Escherichia coli K-12, Infect. Immun. 55:2734-2740 (1987). |
Bjornson et al., Endotoxin-Associated Protein: a Potent Stimulus for Human Granulocytopoietic Activity Which May Be Accessory Cell Independant, Infect. Immun. 56:1602-1607 (1988). |
Blake, M. S. et al., Protein III: Structure, Function, and Genetics, Clin. Microbiol. Rev. 2(Suppl.):S60-S63 (1989). |
Boons, G. J. P. H. et al., Preparation of a Well-Defined Sugar-Peptide Conjugate: A Possible Approach to a Synthetic Vaccine Against Neisseria meningitidis, Bioorganic & Medicinal Chemistry Letters 1:303-308 (1991). |
Bremer, E. et al., Isolation and characterization of mutants deleted for the sulA-ompA region of the Escherichia coli K-12 chromosome, FEMS Microbiol. Lett. 33:173-178 (1986). |
Cowan, S. W. et al., Crystal structures explain functional properties of two E. coli porins, Nature 358:727-733 (1992). |
Feavers, I. M. et al., Molecular Analysis of the Serotyping Antigens of Neisseria meningitidis, Infect. Immun. 60:3620-3629 (1992). |
Frasch, C. E. et al., Serotype Antigens of Neisseria meningitidis and a Proposed Scheme for Designation of Serotypes, Rev. Infect. Dis. 7:504-510 (1985). |
Frasch, C. E., Production and Control of Neisseria meningitidis Vaccines, in Bacterial Vaccines, Alan R. Liss, Inc., pp. 123-145 (1990). |
Freudl, R. et al., A Lower Size Limit Exists for Export of Fragments of an Outer Membrane Protein (OmpA) of Escherichia coli K-12, J. Mol. Biol. 205:771-775 (1989). |
Gotschlich, E. C. et al., Gonococcal protein III. Purification and chemical characterization of the protein, and the DNA sequence of the structural gene, Antonie van Leeuwenhoek 53:455-459 (1987). |
Holzenburg, A. et al., Rapid Isolation of OmpF Porin-LPS Complexes Suitable for Structure-Function Studies, Biochemistry 28:4187-4193 (1989). |
James, L. T. et al., An Improved Method for the Isolation of the Major Protein of the Gonococcal Outer Membrane in an Antigenically Reactive Form, J. Immunol. Meth. 42:223-228 (1981). |
Jennings, H. J., Capsular Polysaccharides as Vaccine Candidates, Current Topics in Microbiology and Immunology 150:105-107 (1990). |
Jennings, H. J. et al., Determinant Specificities of the Groups B and C Polysaccharides of Neisseria meningitidis, J. Immunol. 134:2651-2657 (1985). |
Jennings, H. J. et al., Induction of Meningococcal Group B Polysaccharide-Specific IgG Antibodies in Mice by Using an N-Propionylated B Polysaccharide-Tetanus Toxoid Conjugate Vaccine, J. Immunol. 137:1708-1713 (1986). |
Jennings, H. J. et al., Unique Intermolecular Bacterial Epitope Involving the Homosialopolysaccharide Capsule on the Cell Surface of Group B Neisseria meningitidis and Escherichia coli K1, J. Immunol. 142:3585-3591 (1989). |
Jones, R. B. et al., Resolution of Basic Gonococcal Outer Membrane Proteins by Nonequilibrium pH Gradient Electrophoresis, Infect. Immun. 30:773-780 (1980). |
Klose, M. et al., Internal Deletions in the Gene for an Escherichia coli Outer Membrane Protein Define an Area Possibly Important for Recognition of the Outer membrane by This Polypeptide, J. Biol. Chem. 263:13291-13296 (1988). |
Klose, M. et al., The Influence of Amino Substitutions within the Mature Part of an Escherichia coli Outer Membrane Protein (OmpA) on Assembly of the Polypeptide into Its Membrane, J. Biol. Chem. 263:13297-13302 (1988). |
McGuinness, B. et al., Deduced Amino Acid Sequences of Class 1 Protein (PorA) From Three Strains of Neisseria meningitidis, J. Exp. Med. 171:1871-1882 (1990). |
Murakami, K. et al., Cloning and Characterization of the Structural Gene for the Class 2 Protein of Neisseria meningitidis, Infect. Immun. 57:2318-2323 (1989). |
Novagen Technical Bulletin: Plasmid map of pET-11a(1990). |
Poolman, J. T. et al., Class 1/3 Outer Membrane Protein Vaccine Against Group B, Type 15, Subtype 16 Meningococci, Develop. Biol. Standard. 63:147-152 (1986). |
Poolman, J. T. et al., Purification, Cyanogen Bromide Cleavage, and Amino Terminus Sequencing of Class 1 and Class 3 Outer Membrane Proteins of Meningococci, Infect. Immun. 57:1005-1007 (1989). |
Poolman, J. T. Polysaccharides and Membrane Vaccines, in Bacterial Vaccines, Alan R. Liss, Inc., pp. 57-86 (1990). |
Saukkonen, K. et al., Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay, Vaccine 7:325-328 (1989). |
Sen, K. et al., Trimerization of an in Vitro Synthesized OmpF Porin of Escherichia coli Outer Membrane, J. Biol. Chem. 266:11295-11300 (1991). |
Studier et al., Use of Bacteriophage T7 RNA Polymerase to Direct Selective High-level Expression of Cloned Genes, J. Mol. Biol. 189:113-130 (1986). |
van der Ley, P. et al., Topology of Outer Membrane Porins in Pathogenic Neissria spp., Infect. Immun. 59:2963-2971 (1991). |
Verheul, A. F. M. et al., Preparation, Characterization, and Immunogenicity of Meningococcal Immunotype L2 and L3, 7, 9 Phosphoethanolamine Group-Containing Oligosaccharide-Protein Conjugates, Infect. Immun. 59:843-851 (1991). |
Ward, M. J. et al., Sequence analysis and relationships between meningococcal class 3 serotype proteins and other porins from pathogenic and non-pathogenic Neisseria Species, FEMS Microbiol. Lett. 94:283-289 (1992). |
Wolff, K. et al., The class 3 outer membrane protein (PorB) of Neisseria meningitidis: gene sequence and homology to the gonococcal porin PIA, FEMS Microbiol. Lett. 83:179-185 (1991). |
Young, J. D. E. et al., Functional channel formation associated with cytotoxic T-cell granules, Proc. Natl. Acad. Sci. USA 83:150-154 (1986). |
Carbonetti, N. H., et al., 1987, Proceedings of the National Academy of Sciences, U.S.A., 84: 9084-9088. |
Zapata, G. A., et al., 1992, Molecular Microbiology, 6(23): 3493-3499. |
Muller, N., et al., 1989, Molecular and Biochemical Parasitology, 36:151-160. |
Blake, M. S., et al., 1984, Journal of Experimental Medecine, 159: 452-462. |
Gotschlich, E. C., et al., 1987, Journal of Experimental Medecine, 165: 471-482. |
Lin, S.-W., et al., 1987, Biochemistry, 26: 5267-5274. |
Marston, F., 1986, Biochemical Journal 240(1): 1-12. |
Lehnhardt, S., et al., 1987, The Journal of Biological Chemistry, 262(4): 1716-1719. |
Novagen, Inc., Products Catalogue, 1993, pp. 1 and 36-47, (Novagen, Inc., 597 Science Drive, Madison, Wis. 53711). |
Kroll, D. J., et al., 1993, DNA and Cell Biology, 12(5): 441-453. |
Morona, R., et al., 1985, Molecular and General Genetics, 201: 357-359. |
Dalbey, R. E., et al., 1985, The Journal of Biological Chemistry, 260(29): 15925-15931. |
de Cock, H., et al., 1990, The Journal of Biological Chemistry, 265(8): 4646-4651. |
Freudl, R., et al., 1987, Journal of Bacteriology, 169(1): 66-71. |
Barik, S., et al., 1991, Journal of Virology, 65(4): 1719-1726. |
Bremer, E., et al., 1982, European Journal of Biochemistry, 122: 231. |
Freudl, R., et al., 1986, Journal of Molecular Biology, 188(3): 491-494. |
Furlong, J., et al., 1991, Virology, 182(2): 846-851. |
He, X.-S., et al., 1991, Biochemical and Biophysical Research Communications, 180(2): 994-1001. |
Reid, J., et al., 1988 The Journal of Biological Chemistry, 263(16): 994-1001. |